Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/29646
Title: A survey of experts to identify methods to detect problematic studies: stage 1 of the INveStigating ProblEmatic Clinical Trials in Systematic Reviews project
Other Titles: A survey of experts to identify methods to detect problematic studies: Stage 1 of the INSPECT-SR Project
Authors: Wilkinson, J
Heal, C
Antoniou, GA
Flemying, E
Avenell, A
Barbour, V
Bordewijk, EM
Brown, NJL
Clarke, M
Dumville, J
Grohmann, S
Gurrin, LC
Hayden, JA
Hunter, KE
Lam, E
Lasserson, T
Li, T
Lensen, S
Liu, J
Lundh, A
Meyerowitz-Katz, G
Mol, BW
O'Connell, NE
Parker, L
Redman, B
Seidler, AL
Sheldrick, K
Sydenham, E
Dahly, DL
van Wely, M
Bero, L
Kirkham, JJ
Keywords: research integrity;fraud;fabrication;misconduct;trustworthiness;randomised controlled trials;systematic reviews;forensic analysis;evidence synthesis;critical appraisal;ORCiD: Andreas Lundh https://orcid.org/0000-0002-4982-8680
Issue Date: 31-Aug-2024
Publisher: Elsevier
Citation: Wilkinson, J. et al. (2024) 'A survey of experts to identify methods to detect problematic studies: stage 1 of the INveStigating ProblEmatic Clinical Trials in Systematic Reviews project', Journal of Clinical Epidemiology. 175, 111512, pp. 1 - 10. doi: 10.1016/j.jclinepi.2024.111512.
Abstract: Background and Objective: Randomized controlled trials (RCTs) inform health-care decisions. Unfortunately, some published RCTs contain false data, and some appear to have been entirely fabricated. Systematic reviews are performed to identify and synthesize all RCTs which have been conducted on a given topic. This means that any of these ‘problematic studies’ are likely to be included, but there are no agreed methods for identifying them. The INveStigating ProblEmatic Clinical Trials in Systematic Reviews (INSPECT-SR) project is developing a tool to identify problematic RCTs in systematic reviews of health care-related interventions. The tool will guide the user through a series of ‘checks’ to determine a study's authenticity. The first objective in the development process is to assemble a comprehensive list of checks to consider for inclusion. Methods: We assembled an initial list of checks for assessing the authenticity of research studies, with no restriction to RCTs, and categorized these into five domains: Inspecting results in the paper; Inspecting the research team; Inspecting conduct, governance, and transparency; Inspecting text and publication details; Inspecting the individual participant data. We implemented this list as an online survey, and invited people with expertise and experience of assessing potentially problematic studies to participate through professional networks and online forums. Participants were invited to provide feedback on the checks on the list, and were asked to describe any additional checks they knew of, which were not featured in the list. Results: Extensive feedback on an initial list of 102 checks was provided by 71 participants based in 16 countries across five continents. Fourteen new checks were proposed across the five domains, and suggestions were made to reword checks on the initial list. An updated list of checks was constructed, comprising 116 checks. Many participants expressed a lack of familiarity with statistical checks, and emphasized the importance of feasibility of the tool. Conclusion: A comprehensive list of trustworthiness checks has been produced. The checks will be evaluated to determine which should be included in the INSPECT-SR tool.
Description: Data availability: The study dataset is available at https://osf.io/6pmx5/.
Supplementary data are available online at: https://www.sciencedirect.com/science/article/pii/S0895435624002683#appsec1 .
A preprint version of this article is available on medRxiv at: https://www.medrxiv.org/content/10.1101/2024.03.18.24304479v2 . It has not been certified by peer review.
URI: https://bura.brunel.ac.uk/handle/2438/29646
DOI: https://doi.org/10.1016/j.jclinepi.2024.111512
ISSN: 0895-4356
Other Identifiers: ORCiD: Jack Wilkinson https://orcid.org/0000-0003-3513-4677
ORCiD: Calvin Heal https://orcid.org/0000-0002-6445-1551
ORCiD: George A. Antoniou https://orcid.org/0000-0001-8209-0406
ORCiD: Ella Flemyng https://orcid.org/0000-0002-9845-9076
ORCiD: Alison Avenell https://orcid.org/0000-0003-4813-5628
ORCiD: Esmee M. Bordewijk https://orcid.org/0000-0001-7983-1613
ORCiD: Nicholas J.L. Brown https://orcid.org/0000-0003-1579-0730
ORCiD: Mike Clarke https://orcid.org/0000-0002-2926-7257
ORCiD: Lyle C. Gurrin https://orcid.org/0000-0001-7052-1969
ORCiD: Lyle C. Gurrin https://orcid.org/0000-0001-7052-1969
ORCiD: Jill A. Hayden https://orcid.org/0000-0001-7026-144X
ORCiD: Kylie E. Hunter https://orcid.org/0000-0002-2796-9220
ORCiD: Sarah Lensen https://orcid.org/0000-0002-1694-1142
ORCiD: Neil O'Connell https://orcid.org/0000-0003-1989-4537
ORCiD: Lisa Parker https://orcid.org/0000-0001-8635-6953
ORCiD: Emma Sydenham https://orcid.org/0000-0002-1471-4237
ORCiD: Darren L. Dahly https://orcid.org/0000-0003-0110-324X
ORCiD: Madelon van Wely https://orcid.org/0000-0001-8263-213X
ORCiD: Jamie J. Kirkham https://orcid.org/0000-0003-2579-9325
111512
Appears in Collections:Dept of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2024 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).352.77 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons